Statistics
Publications
5
Citations
73
H-Index
5
Active since
2022
Affiliations
Hangzhou Normal University(Current)
Jiayun Xu is an author at Hangzhou Normal University specializing in pharmacology, glioblastoma, and glioblastoma targeted therapy.
Publications per year
2022–2025
5
5
Atractylon inhibits the tumorigenesis of glioblastoma through SIRT3 signaling.
Shanshan Sun, Jiali Shi, Xin Wang et al. · PubMed · 2022 · 23 citations · Full text
Medicine, Oncology, Pharmacology +17
Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
Jiayun Xu, Shanshan Sun, Wei Zhang et al. · Frontiers in Pharmacology · 2022 · 11 citations · Full text
Medicine, Oncology, Pharmacology +15
Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway
Wei Zhang, Jianhong Dong, Jiayun Xu et al. · Biochemical Pharmacology · 2024 · 11 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 5